Central Pacific Bank Trust Division Cuts Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Central Pacific Bank Trust Division lowered its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 20.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 484 shares of the company’s stock after selling 126 shares during the quarter. Central Pacific Bank Trust Division’s holdings in HCA Healthcare were worth $145,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Terra Nova Asset Management LLC lifted its position in shares of HCA Healthcare by 0.3% during the 3rd quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock valued at $3,297,000 after acquiring an additional 26 shares during the period. Massmutual Trust Co. FSB ADV boosted its position in HCA Healthcare by 7.4% during the third quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock worth $171,000 after purchasing an additional 29 shares in the last quarter. Waldron Private Wealth LLC raised its stake in shares of HCA Healthcare by 1.8% during the 3rd quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock worth $683,000 after buying an additional 29 shares during the last quarter. Brookstone Capital Management grew its stake in HCA Healthcare by 0.7% in the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock valued at $1,652,000 after acquiring an additional 30 shares during the last quarter. Finally, UMB Bank n.a. lifted its holdings in shares of HCA Healthcare by 2.4% in the third quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock valued at $529,000 after purchasing an additional 30 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the company. Raymond James lowered HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. StockNews.com downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. KeyCorp cut their price objective on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. TD Cowen cut their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a report on Monday, October 28th. Finally, Morgan Stanley lowered their price objective on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $391.27.

HCA Healthcare Stock Down 0.4 %

Shares of HCA Healthcare stock opened at $296.70 on Friday. The company has a fifty day moving average price of $326.93 and a 200 day moving average price of $354.79. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a twelve month low of $271.13 and a twelve month high of $417.14. The stock has a market cap of $75.15 billion, a price-to-earnings ratio of 13.32, a price-to-earnings-growth ratio of 1.21 and a beta of 1.64.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Friday, December 13th were issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.89%. The ex-dividend date of this dividend was Friday, December 13th. HCA Healthcare’s dividend payout ratio is presently 11.85%.

Insider Activity

In related news, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.